Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses
Main Authors: | Haruko Yamamoto, Hiroshi Suzuki |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-10-01
|
Series: | EClinicalMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589537022003315 |
Similar Items
-
Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial
by: Hideto Yamada, et al.
Published: (2022-08-01) -
Author's reply – Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial
by: Hideto Yamada, et al.
Published: (2022-10-01) -
Live Birth Rate in Women with Recurrent Pregnancy Loss after In Vitro Fertilization with Concomitant Intravenous Immunoglobulin and Prednisone
by: Pia Egerup, et al.
Published: (2022-03-01) -
Successful Pregnancy and Delivery at Term Following Intravenous Immunoglobulin Therapy with Heparin for Unexplained Recurrent Pregnancy Loss Suspected of Immunological Abnormalities: A Case Report and Brief Literature Review
by: Junichiro Mitsui, et al.
Published: (2023-02-01) -
Exquisite response to intravenous immunoglobulin in Susac syndrome during pregnancy
by: Enrique Gomez-Figueroa, et al.
Published: (2018-03-01)